Found: 95
Select item for more details and to access through your institution.
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 134, doi. 10.1007/s10637-021-01170-x
- By:
- Publication type:
- Article
Holistic review for hematology‐oncology fellowship applicants: A new paradigm?
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1124, doi. 10.1002/ajh.25930
- By:
- Publication type:
- Article
Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors.
- Published in:
- CA: A Cancer Journal for Clinicians, 2024, v. 74, n. 4, p. 359, doi. 10.3322/caac.21840
- By:
- Publication type:
- Article
Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Leptomeningeal Carcinomatosis in Colorectal Cancer: The Mayo Clinic Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.651119
- By:
- Publication type:
- Article
Oral Cancer Chemotherapy: The Critical Interplay Between Patient Education and Patient Safety.
- Published in:
- Current Oncology Reports, 2010, v. 12, n. 4, p. 247, doi. 10.1007/s11912-010-0103-6
- By:
- Publication type:
- Article
Liver metastases from pituitary carcinomas mimicking visceral well-differentiated neuroendocrine tumors: a series of four cases.
- Published in:
- Diagnostic Pathology, 2020, v. 15, n. 1, p. 1, doi. 10.1186/s13000-020-00997-x
- By:
- Publication type:
- Article
Targeted Alpha-Particle Therapy: A Review of Current Trials.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11626, doi. 10.3390/ijms241411626
- By:
- Publication type:
- Article
Understanding Suboptimal Response to Immune Checkpoint Inhibitors.
- Published in:
- Advanced Biology, 2023, v. 7, n. 4, p. 1, doi. 10.1002/adbi.202101319
- By:
- Publication type:
- Article
Pilot Study Characterizing the Hematology-Oncology Fellow Job Search Process: Tools Used and Identification of Potential New Resources.
- Published in:
- Journal of Cancer Education, 2022, v. 37, n. 5, p. 1385, doi. 10.1007/s13187-021-01967-7
- By:
- Publication type:
- Article
ASO Author Reflections: Presacral Neuroendocrine Neoplasms—Insights into a Rare Disease.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 8, p. 5228, doi. 10.1245/s10434-024-15472-w
- By:
- Publication type:
- Article
Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive Hepatectomy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 8, p. 4931, doi. 10.1245/s10434-024-15374-x
- By:
- Publication type:
- Article
Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 8, p. 5370, doi. 10.1245/s10434-024-15316-7
- By:
- Publication type:
- Article
Presacral Neuroendocrine Neoplasms: A Multi-site Review of Surgical Outcomes.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 7, p. 4551, doi. 10.1245/s10434-024-15328-3
- By:
- Publication type:
- Article
Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Reply to "Residual Tumor Volume, Not Percent Cytoreduction, Matters for Surgery of Neuroendocrine Liver Metastasis".
- Published in:
- 2023
- By:
- Publication type:
- Letter
ASO Visual Abstract: Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases—Long-Term Follow-Up of Over 500 Patients.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
ASO Author Reflections: Long-Term Outcomes after Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 8, p. 4852, doi. 10.1245/s10434-023-13374-x
- By:
- Publication type:
- Article
Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 8, p. 4840, doi. 10.1245/s10434-023-13372-z
- By:
- Publication type:
- Article
ASO Author Reflections: Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors—A Single Operation is Feasible in Most Patients.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 11, p. 6958, doi. 10.1245/s10434-022-12106-x
- By:
- Publication type:
- Article
Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 11, p. 6949, doi. 10.1245/s10434-022-12029-7
- By:
- Publication type:
- Article
Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 5, p. 3072, doi. 10.1245/s10434-022-11371-0
- By:
- Publication type:
- Article
The Quality of Online Information for an Uncommon Malignancy--Neuroendocrine Tumours (NETs).
- Published in:
- Current Oncology, 2021, v. 28, n. 1, p. 842, doi. 10.3390/curroncol28010082
- By:
- Publication type:
- Article
Risk of non-hormonal cancer after bariatric surgery: meta-analysis of retrospective observational studies.
- Published in:
- British Journal of Surgery, 2023, v. 110, n. 1, p. 24, doi. 10.1093/bjs/znac343
- By:
- Publication type:
- Article
Accuracy of DOTATATE PET imaging in the preoperative planning of small bowel neuroendocrine tumor resection.
- Published in:
- Journal of Surgical Oncology, 2023, v. 128, n. 7, p. 1072, doi. 10.1002/jso.27413
- By:
- Publication type:
- Article
Multifocality is not associated with worse survival in sporadic pancreatic neuroendocrine tumors.
- Published in:
- Journal of Surgical Oncology, 2021, v. 124, n. 7, p. 1077, doi. 10.1002/jso.26618
- By:
- Publication type:
- Article
Current Status and Perspectives of Targeted Therapy in Well-Differentiated Neuroendocrine Tumors.
- Published in:
- Oncology, 2012, v. 83, n. 3, p. 117, doi. 10.1159/000339539
- By:
- Publication type:
- Article
Mayo Clinic Cancer Center experience of metastatic extramammary Paget disease 1998-2012.
- Published in:
- Rare Tumors, 2016, v. 8, n. 4, p. 142, doi. 10.4081/rt.2016.6804
- By:
- Publication type:
- Article
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 10, p. 1127, doi. 10.1007/s11912-023-01438-w
- By:
- Publication type:
- Article
Incidence and Management of Gastrointestinal Perforation from Bevacizumab in Advanced Cancers.
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 4, p. 277, doi. 10.1007/s11912-012-0238-8
- By:
- Publication type:
- Article
Evaluation of Hepatotoxicity from Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors and a Very High Liver Tumor Burden.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 6, p. 880, doi. 10.2967/jnumed.122.264533
- By:
- Publication type:
- Article
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy (PRRT).
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262048
- By:
- Publication type:
- Article
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy (PRRT).
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262048
- By:
- Publication type:
- Article
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy (PRRT).
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262048
- By:
- Publication type:
- Article
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy (PRRT).
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262048
- By:
- Publication type:
- Article
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy (PRRT).
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.262048
- By:
- Publication type:
- Article
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy (PRRT).
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 21, doi. 10.2967/jnumed.121.262048
- By:
- Publication type:
- Article
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy (PRRT).
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.121.262048
- By:
- Publication type:
- Article
Patient travel concerns after treatment with Lu-177 DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.243238
- By:
- Publication type:
- Article
Patient travel concerns after treatment with Lu-177 DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.243238
- By:
- Publication type:
- Article
Patient travel concerns after treatment with Lu-177 DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.243238
- By:
- Publication type:
- Article
Patient travel concerns after treatment with Lu-177 DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.243238
- By:
- Publication type:
- Article
Patient travel concerns after treatment with Lu-177 DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.243238
- By:
- Publication type:
- Article
Patient travel concerns after treatment with Lu-177 DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.243238
- By:
- Publication type:
- Article
Patient travel concerns after treatment with Lu-177 DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.120.243238
- By:
- Publication type:
- Article
PET/CT and PET/MRI in neuroendocrine neoplasms.
- Published in:
- Abdominal Radiology, 2022, v. 47, n. 12, p. 4058, doi. 10.1007/s00261-022-03516-2
- By:
- Publication type:
- Article
Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis.
- Published in:
- Oncologist, 2022, v. 27, n. 7, p. 573, doi. 10.1093/oncolo/oyac049
- By:
- Publication type:
- Article